Industry Updates

Fixing a Genetic Flaw22 Mar

A novel form of antisense therapy known as exon skipping proves
successful in treating a variant of muscular dystrophy in dogs in the
lab.

http://www.technologyreview.com/biomedicine/22327/

2 Responses to “Fixing a Genetic Flaw”

  1. growler_south

    Now that’s clever! Not replacing the missing DNA, but fixing what good DNA is there to make the gene work as well as it can.

  2. biotechbeachbum

    Yeah, pretty cool, huh? Antisense approaches are still expensive and difficult to deliver – these poor dogs had to put up with constant injections – but where those issues can be surmounted they can solve problems very hard to tackle with traditional drugs.

    We miss you, btw – when are you coming to visit San Diego?

Leave a Reply

Company News

  • - 2010/10/24

    We're currently working with online elections provider Everyone Counts, Inc. Contact us to find out more!

  • - 2010/03/01

    We're currently working with the Life Sciences IT Global Institute to define Good Informatics Practices for Data Management in Life Sciences and Healthcare, and working on solutions in data mining for scientific applications. Contact us to find out more!

Contact Us

Email contact@dotgentech.com

DOTGEN TECHNOLOGIES INC.
PO BOX 4095
San Diego, CA 92164-4095